These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

634 related items for PubMed ID: 15847852

  • 1. Neurohormonal activation in congestive heart failure and the role of vasopressin.
    Chatterjee K.
    Am J Cardiol; 2005 May 02; 95(9A):8B-13B. PubMed ID: 15847852
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Neuro-hormonal mechanisms in heart failure -- from physiopathology to treatment].
    Cerqueira-Gomes M, Polónia J, Brandão F, Ramalhão C, da Faria DB.
    Rev Port Cardiol; 2001 May 02; 20 Suppl 5():V-99-122; discussion V-123-5. PubMed ID: 11515306
    [Abstract] [Full Text] [Related]

  • 4. [Neurohormonal factors in heart failure. II].
    Cosín Aguilar J, Cruz Fernández JM, de Teresa Galván E, Ferreira Montero IJ, López-Sendón J, Soler Soler J, Tamargo Menéndez J.
    Rev Esp Cardiol; 1996 May 02; 49(5):317-27. PubMed ID: 8744385
    [Abstract] [Full Text] [Related]

  • 5. [Neurohormonal factors in congestive heart failure].
    Hannedouche T, Fournier JF.
    Ann Med Interne (Paris); 1987 May 02; 138(2):123-9. PubMed ID: 3555207
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Adaptive and maladaptive actions of angiotensin II in patients with severe congestive heart failure.
    Packer M.
    Am J Kidney Dis; 1987 Jul 02; 10(1 Suppl 1):66-73. PubMed ID: 3037891
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Activation of the renin-angiotensin-aldosterone system in heart failure].
    Volpe M, Tocci G, Pagannone E.
    Ital Heart J; 2005 May 02; 6 Suppl 1():16S-23S. PubMed ID: 15945296
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Vasopressin: a new target for the treatment of heart failure.
    Lee CR, Watkins ML, Patterson JH, Gattis W, O'connor CM, Gheorghiade M, Adams KF.
    Am Heart J; 2003 Jul 02; 146(1):9-18. PubMed ID: 12851603
    [Abstract] [Full Text] [Related]

  • 13. Vasopressin and vasopressin receptor antagonists in heart failure.
    Oghlakian G, Klapholz M.
    Cardiol Rev; 2009 Jul 02; 17(1):10-5. PubMed ID: 19092365
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hyponatremia in heart failure: the role of arginine vasopressin and its antagonism.
    Rosner MH, Ronco C.
    Congest Heart Fail; 2010 Jul 02; 16 Suppl 1():S7-14. PubMed ID: 20653716
    [Abstract] [Full Text] [Related]

  • 17. [Neurohormonal assessment in heart failure: from the sophisticated laboratory to practical indications].
    Dei Cas L, Metra M, Visioli O.
    G Ital Cardiol; 1993 Feb 02; 23(2):193-204. PubMed ID: 8098306
    [Abstract] [Full Text] [Related]

  • 18. Pathophysiology and clinical spectrum of acute congestive heart failure.
    Shah M, Ali V, Lamba S, Abraham WT.
    Rev Cardiovasc Med; 2001 Feb 02; 2 Suppl 2():S2-6. PubMed ID: 12439355
    [Abstract] [Full Text] [Related]

  • 19. Neurohormonal activity in congestive heart failure.
    Kubo SH.
    Crit Care Med; 1990 Jan 02; 18(1 Pt 2):S39-44. PubMed ID: 2136721
    [Abstract] [Full Text] [Related]

  • 20. Prevention of remodeling in congestive heart failure due to myocardial infarction by blockade of the renin-angiotensin system.
    Guo X, Saini HK, Wang J, Gupta SK, Goyal RK, Dhalla NS.
    Expert Rev Cardiovasc Ther; 2005 Jul 02; 3(4):717-32. PubMed ID: 16076281
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 32.